Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

PRALSETINIB vs PRAZEPAM: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

PRALSETINIB vs PRAZEPAM: Safety Overview

Metric PRALSETINIB PRAZEPAM
Total FAERS Reports 1,419 1,721
Deaths Reported 226 154
Death Rate 15.9% 8.9%
Hospitalizations 431 1,080
Average Patient Age 61.9 yrs 48.9 yrs
% Female Patients 56.6% 63.2%
FDA Approval Date Sep 4, 2020 Approved Prior to Jan 1, 1982
Manufacturer Genentech, Inc. N/A
Route ORAL N/A
Marketing Status Prescription Discontinued